Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis

BACKGROUND: Inhaled bronchodilators including long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA) play a central role in the treatment of stable chronic obstructive pulmonary disease (COPD). However, it is still unclear whether LABA or LAMA should be used for the initial tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Koarai, Akira, Sugiura, Hisatoshi, Yamada, Mitsuhiro, Ichikawa, Tomohiro, Fujino, Naoya, Kawayama, Tomotaka, Ichinose, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191827/
https://www.ncbi.nlm.nih.gov/pubmed/32349720
http://dx.doi.org/10.1186/s12890-020-1152-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191827/
https://www.ncbi.nlm.nih.gov/pubmed/32349720
http://dx.doi.org/10.1186/s12890-020-1152-8

Ejemplares similares